Tennessee Gov. Bill Lee signed into law a bill that expands coverage of biomarker testing for patients enrolled in state ...

Primary care clinicians with higher diagnostic confidence are adopting emerging blood-based Alzheimer’s disease tests, ...

Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a collaboration with Tempus AI Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance ...

Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

At-home biomarker testing is gaining popularity as an alternative to traditional lab visits for routine blood work. Companies like SiPhox Health offer kits to test for dozens of health markers from ...

New blood tests measuring p-tau217 levels show promise for predicting Alzheimer's risk years before symptoms appear, though ...

BeiGene is back with a new partnership and oncology campaign to raise awareness about biomarker testing for patients with chronic lymphocytic leukemia (CLL), a blood cancer marked by the ...

Keith W. Roach, MD, is an associate professor of clinical medicine in the division of general medicine at NewYork-Presbyterian. Christopher Kelly, MD, from UNC Health, is a general cardiologist who ...

Despite the clinical utility of biomarker testing in patients with prostate cancer, the tests are infrequently ordered, preventing optimized care. Despite guideline recommendations and the efficacy of ...

Governor Bill Lee signed a bill into law Friday that will require insurance companies to cover biomarker testing.